Active Ingredient: Frovatriptan
Acute treatment of the headache phase of migraine attacks with or without aura.
For this indication, competent medicine agencies globally authorize below treatments:
Oral
2.5 - 5 mg
From 2.5 To 5 mg once every day
Frovatriptan should be taken as early as possible after the onset of a migraine attack but it is also effective when taken at a later stage. Frovatriptan should not be used prophylactically.
If a patient does not respond to the first dose of frovatriptan, a second dose should not be taken for the same attack, since no benefit has been shown.
Frovatriptan may be used for subsequent migraine attacks.
The recommended dose of frovatriptan is 2.5 mg.
If the migraine recurs after initial relief, a second dose may be taken, providing there is an interval of at least 2 hours between the two doses.
The total daily dose should not exceed 5 mg per day.
The frovatriptan tablets should be swallowed whole with water.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
